Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panzem NCD + Bevacizumab in Carcinoid Tumors
NCT00328497Phase 2Completed
- Sponsor
- CASI Pharmaceuticals, Inc.
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-methoxyestradiol in Carcinoid Tumor (CT), sponsored by CASI Pharmaceuticals, Inc.. Started May 2006; status: completed.
02
Drugs
2-methoxyestradiol
03
Conditions
Carcinoid Tumor (CT)
Beyond the preview
Go deeper on NCT00328497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328497.